.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Preethi Korangath

Baltimore, US

Johns Hopkins University

Vortrag

29.09.2023
14:48 – 15:00 10 Min. 2 Min.
Systemic treatment with iron oxide nanoparticles inhibits the progression of metastatic cancer by altering the host immune profile in mouse models of breast cancer
Hyperthermia Drug Delivery, Nanoparticles

Weitere Beteiligungen

29.09.2023
14:48 – 15:00 10 Min. 2 Min.
Systemic treatment with iron oxide nanoparticles inhibits the progression of metastatic cancer by altering the host immune profile in mouse models of breast cancer
Hyperthermia Drug Delivery, Nanoparticles